Allergic Conditions Associated with Reduced Brain Tumor Risk: Meta-Analysis Insights
Overview
A meta-analysis of 40 observational studies found that a history of allergic conditions is associated with a significantly decreased risk of brain tumors. This inverse association was prominent in case–control studies but not observed in cohort studies.
Background
Brain tumors, including glioma, meningioma, and acoustic neuroma, represent a significant portion of central nervous system neoplasms with an incidence of approximately 14.4 per 100,000 persons annually. Prior epidemiological studies have explored various risk factors, including allergic conditions such as hay fever, eczema, and asthma. However, consensus on the relationship between allergy and brain tumor risk has not been reached, with previous meta-analyses focusing mainly on glioma and involving few cohort studies.
Data Highlights
Study Type
Number of Studies
Odds Ratio (OR)
95% Confidence Interval (CI)
All studies (n=37)
37
0.78
0.71–0.86
Case–control studies
31
0.71
0.63–0.79
Cohort studies
9
1.00
0.85–1.19
Key Findings
History of allergic conditions is associated with a 22% reduced risk of brain tumors overall (OR 0.78, 95% CI 0.71–0.86).
Case–control studies showed a stronger inverse association (OR 0.71, 95% CI 0.63–0.79).
Cohort studies did not demonstrate a significant association (OR 1.00, 95% CI 0.85–1.19).
No significant publication bias was detected (Begg’s test p = 0.703).
Risk of bias assessment rated most studies as moderate risk, with only one study at critical risk and one at high risk.
Subgroup analyses by allergic condition type, tumor type, age, region, study design, tumor grade, gender, and number of allergic conditions were conducted for detailed insights.
Clinical Implications
Clinicians should consider the potential protective association between allergic conditions and brain tumor risk when evaluating patient histories. While case–control data support this inverse relationship, cohort data are inconclusive, highlighting the need for cautious interpretation. Further prospective studies are warranted to clarify the underlying mechanisms and confirm these findings.
Conclusion
This comprehensive meta-analysis suggests that allergic conditions may confer a decreased risk of brain tumors, particularly supported by case–control evidence. These findings contribute to the evolving understanding of brain tumor etiology and may inform future research and risk assessment strategies.
